Alternatives to Entecavir If You Can't Fill Your Prescription

Entecavir is one of the two first-line treatments for chronic hepatitis B recommended by major medical guidelines—the other being tenofovir. So if your pharmacy is out of entecavir, you're not without options. But any switch must be made with your doctor's direct involvement. Stopping entecavir abruptly without a plan carries serious risks.

This guide explains the main alternatives to entecavir, how they compare, and what questions to bring to your hepatologist or gastroenterologist.

Why Switching Hepatitis B Medications Requires Medical Supervision

Entecavir carries an FDA boxed warning: stopping treatment can trigger severe acute exacerbations of hepatitis B. Your liver enzymes and HBV DNA levels must be monitored for at least several months after any change in therapy. Your doctor needs to know before you stop, switch, or skip doses.

The good news: if you switch from entecavir to another first-line agent, the transition can typically be done without a dangerous gap in protection—provided it's managed properly.

Option 1: Tenofovir Disoproxil Fumarate (TDF) — Viread

Tenofovir disoproxil fumarate (TDF, sold as Viread) is the other recommended first-line treatment for chronic hepatitis B. Like entecavir, it has a high genetic barrier to resistance and potent antiviral activity—achieving undetectable HBV DNA levels in 68–90% of patients after 48 weeks of therapy.

Key differences from entecavir:

• Bone and kidney effects: TDF is associated with greater risk of bone density loss and kidney problems than entecavir. Monitoring is recommended.
• Pregnancy: TDF is often preferred during pregnancy (FDA Category B) because it also reduces mother-to-child transmission of HBV.
• HIV/HBV co-infection: TDF (as part of an HIV regimen) is generally preferred over entecavir in patients co-infected with both HIV and HBV.
• Cost: Generic TDF (Viread) is widely available and often inexpensive with discount cards.

Option 2: Tenofovir Alafenamide (TAF) — Vemlidy

Tenofovir alafenamide (TAF, brand name Vemlidy) is a newer formulation of tenofovir approved in 2016. It delivers tenofovir primarily to the liver—resulting in much lower blood levels of the drug and fewer bone and kidney side effects compared to TDF.

Key features:

• Preferred for patients with pre-existing kidney problems or osteoporosis
• Still brand-name only as of early 2026—significantly more expensive than generic entecavir or TDF
• Gilead offers a patient assistance program (PAP) for uninsured or underinsured patients

Option 3: Lamivudine (3TC) — Epivir-HBV

Lamivudine was once the standard of care for hepatitis B, but it is now rarely used as first-line therapy because of its high resistance rate—about 70% of patients develop lamivudine-resistant HBV after 5 years of treatment. It remains available and inexpensive, and may be used in specific circumstances, but it would not be a preferred long-term replacement for entecavir.

Option 4: Pegylated Interferon Alfa-2a (Pegasys)

Pegylated interferon is an injectable immunomodulator taken weekly for 48 weeks. Unlike oral antivirals, it has a defined treatment endpoint and can lead to lasting immune control without lifelong therapy in some patients. However, it has a more challenging side effect profile (flu-like symptoms, mood changes) and is contraindicated in decompensated cirrhosis. It's not a direct swap for entecavir but may be considered by your doctor for specific clinical situations.

Head-to-Head: Entecavir vs. Its Alternatives

According to the 2025 AASLD/IDSA Hepatitis B Treatment Guidelines, entecavir, tenofovir DF, and tenofovir alafenamide are all considered preferred first-line agents for most adults. All three have high antiviral potency and a high genetic barrier to resistance. The choice between them is usually guided by patient-specific factors: kidney function, bone health, pregnancy status, HIV co-infection, and cost.

What to Tell Your Doctor

If you're having trouble finding entecavir, call your doctor's office and say:

• "I cannot fill my entecavir prescription. I have [X days'] supply left."
• "Can you help me locate it, or should we consider switching to tenofovir temporarily?"
• "Do you have any samples that could bridge me while I locate a pharmacy?"

Finding Entecavir Before You Need an Alternative

The best outcome is finding entecavir itself rather than switching. medfinder can call pharmacies near you to find which ones have it in stock. Check out our guide on how to find entecavir in stock near you for a full step-by-step approach.